Latest Breaking News On - புனர்வாழ்வு கண்டுபிடிப்பு - Page 1 : comparemela.com

FDA Warns About Johnson & Johnson COVID Vaccine and Guillain-Barré Syndrome Risk Here s What That Means Health.com 2 hrs ago © Provided by Health.com Getty / Photo Illustration by Jo Imperio The US Food and Drug Administration (FDA) has released a new warning that the one-dose Johnson & Johnson (Janssen) COVID-19 vaccine could increase people s risk of developing Guillain-Barré syndrome (GBS), a rare neurological disorder. The FDA added the warning to the vaccine s fact sheet on Monday. The announcement comes after an analysis of the data from the Vaccine Adverse Event Reporting System (VAERS) a national early warning system to detect possible safety problems in vaccines licensed in the US showed that 100 people reportedly developed GBS after receiving the Johnson & Johnson COVID-19 vaccine, an FDA official tells

New yorkUnited statesJohnson janssenDennisl kolsonJo imperioAmesha adaljaEpstein barrDavid putrinoCenters for diseaseDrug administrationJohns hopkins centerHealth securityRehabilitation innovation for mount sinai health systemNational institute of neurological diseasesPhoto illustrationVaccine adverse event reporting system